Kendle adds OmniComm’s TrialMaster EDC solution to e-clinical offerings

Leading global CRO Kendle announced in October that it will add OmniComm’s TrialMaster EDC solution to its current e-clinical offerings in a multi-year enterprise-wide agreement.

CINCINNATI, Ohio—Leading global CRO Kendle announced inOctober that it will add OmniComm's TrialMaster EDC solution to its currente-clinical offerings in a multi-year enterprise-wide agreement. Financialdetails of the agreement were not released. John Fontenault, executive directorand global head of clinical data management and technology, says the additionof TrialMaster EDC to the company's offerings will add "efficient delivery ofhigh-quality data," is critical to Kendle's continued success as a provider ofPhase I to IV clinical data management services."
 
 
"The TrialMaster platform offers the right mix offunctionality to streamline the study development process and drive efficientstudy operations," Fontenault says. 


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

February 2023 Front Cover

Latest Issue  

• Volume 19 • Issue 2 • February 2023

February 2023

February 2023 Issue